16.39 USD
▲+1.02+3.21%
盘后 15.80 -0.50%
2026-08-03
市值
$1.73B
市盈率
25.70
EPS
0.64
股息率
—
52 周区间
14.68 – 25.32
成交量
2.88M
Beta
0.20
目标价
22.17
52W 低 14.6852W 高 25.32
价格走势
公司简介
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; ...